Mostrando resultados 1 a 20 de 53
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | mar-2006 | 18F-choline images murine atherosclerotic plaques ex vivo | Matter, Christian M.; Wyss, Matthias T.; Meier, Patricia; Lohmann, Christine; Weber, Bruno; Ramírez de Molina, Ana CSIC ORCID; Ametamey, Simon M.; Lacal, Juan Carlos CSIC ORCID; Kaufmann, Philipp A.; Buck, Alfred | artículo |
| closedAccess |  | 2012 | Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition | Ramírez de Molina, Ana CSIC ORCID; Cueva, Ana de la CSIC; Machado-Pinilla, R. CSIC; Rodriguez-Fanjul, V. CSIC ORCID; Gómez del Pulgar, Teresa CSIC; Cebrián, Arancha CSIC ORCID; Perona Abellón, Rosario CSIC ORCID; Lacal, Juan Carlos CSIC ORCID | artículo |
| openAccess |  | feb-1995 | Activation of intracellular kinases in Xenopus oocytes by p21ras and phospholipases: a comparative study | Carnero, Amancio CSIC ORCID; Lacal, Juan Carlos CSIC ORCID | artículo |
| closedAccess |  | 1-mar-1997 | Activation of phospholipase D by growth factors and oncogenes in murine fibroblasts follow alternative but cross-talking pathways | Peso, Luis del CSIC ORCID; Lucas, Luisa CSIC; Esteve, Pilar CSIC ORCID ; Lacal, Juan Carlos CSIC ORCID | artículo |
| closedAccess |  | 1999 | Activation of serum response factor by RhoA is mediated by the nuclear factor-κB and C/EBP transcription factors | Montaner, Silvia CSIC; Perona Abellón, Rosario CSIC ORCID; Saniger, Luisa; Lacal, Juan Carlos CSIC ORCID | artículo |
| openAccess |  | 6-dic-2007 | Alpha anticholine kinase monoclonal antibodies and their use in analytical techniques for the diagnosis of cancer and the preparation of medicinal products | Ramírez de Molina, Ana CSIC ORCID; Gallego Ortega, David CSIC ORCID; Lacal, Juan Carlos CSIC ORCID | patente |
| openAccess |  | dic-2000 | Apoptosis induced by Rac GTPase correlates with induction of FasL and ceramides production | Embade, Nieves CSIC ORCID; Valerón, Pilar F.; Aznar, Salvador CSIC ORCID; López-Collazo, Eduardo CSIC; Lacal, Juan Carlos CSIC ORCID | artículo |
| closedAccess |  | 2011 | Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics | Casado-Vela, Juan CSIC ORCID CVN; Cebrián, Arancha CSIC ORCID; Gómez del Pulgar, Teresa CSIC; Lacal, Juan Carlos CSIC ORCID | artículo |
| openAccess |  | ago-2002 | Cell stress and MEKK1-mediated c-Jun activation modulate NFkappaB activity and cell viability | Sánchez-Pérez, Isabel CSIC ORCID; Aznar, Salvador CSIC ORCID; Martínez-Gomariz, Montserrat; Lacal, Juan Carlos CSIC ORCID; Perona Abellón, Rosario CSIC ORCID | artículo |
| openAccess |  | 2006 | Changing the course of oncogenesis: The development of tyrosine kinase inhibitors | Lacal, Juan Carlos CSIC ORCID | artículo |
| closedAccess | | dic-2008 | Choline kinase alpha depletion selectively kills tumoral cells | Báñez Coronel, Mónica CSIC; Ramírez de Molina, Ana CSIC ORCID; Rodríguez-González, Agustín; Sarmentero, Jacinto; Ramos, Mª Angeles; García Cabezas, Miguel Ángel; Garcia-Oroz, Lourdes; Lacal, Juan Carlos CSIC ORCID | artículo |
| openAccess |  | 28-nov-2013 | Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells | Sánchez-López, E.; Zimmerman, T. CSIC; Gómez del Pulgar, Teresa CSIC; Moyer, M.P.; Lacal, Juan Carlos CSIC ORCID; Cebrián, Arancha CSIC ORCID | artículo |
| closedAccess |  | 2004 | Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action | Rodríguez-González, Agustín; Ramírez de Molina, Ana CSIC ORCID; Fernández, Félix; Lacal, Juan Carlos CSIC ORCID | artículo |
| closedAccess |  | 2005 | Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis | Ramírez de Molina, Ana CSIC ORCID; Gallego Ortega, David CSIC ORCID; Sarmentero Estrada, Jacinto CSIC; Báñez Coronel, Mónica CSIC; Martín, Yolanda; Lacal, Juan Carlos CSIC ORCID | artículo |
| openAccess |  | 2022 | Choline kinase α inhibitors MN58b and RSM932A enhances the antitumor response to cisplatin in lung tumor cells | Lacal, Juan Carlos CSIC ORCID; Perona Abellón, Rosario CSIC ORCID; Castro, Javier de; Cebrián, Arancha CSIC ORCID | artículo |
| openAccess |  | 2021 | Choline kinase: An unexpected journey for a precision medicine strategy in human diseases | Lacal, Juan Carlos CSIC ORCID; Zimmerman, Tahl; Campos, Joaquín M. | artículo de revisión |
| openAccess |  | 2013 | Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: Evidence in human tumor-derived cell lines and mouse xenografts | Cueva, Ana de la CSIC; Ramírez de Molina, Ana CSIC ORCID; Álvarez-Ayerza, Néstor CSIC; Ramos, Maria Angeles CSIC; Cebrián, Arancha CSIC ORCID; Gómez del Pulgar, Teresa CSIC; Lacal, Juan Carlos CSIC ORCID | artículo |
| openAccess |  | 5-mar-2015 | Compositions and methods for characterization and amelioration of rheumatoid arthritis | Firestein, Gary S.; Guma, Mónica; Karin, Michael; Sánchez-López, Elsa CSIC ORCID CVN; Lacal, Juan Carlos CSIC ORCID; Tiziani, Stefano | patente |
| openAccess |  | 1-abr-2008 | Derivados de triterpenoquinonas y triterpenofenoles y su aplicación para el tratamiento de tumores y enfermedades parasitarias | Lacal, Juan Carlos CSIC ORCID; Ramírez de Molina, Ana CSIC ORCID; Báñez Coronel, Mónica CSIC; Gutiérrez Ravelo, Ángel; Estévez-Braun, Ana; Mesa Siverio, Dulce Y.; Pérez Sacau, Elisa | patente |
| openAccess |  | 15-abr-2010 | Derivatives of pyridine and quinoline | Lacal, Juan Carlos CSIC ORCID; Campos Rosa, Joaquín M.; Gallo Meza, Miguel Angel; Espinosa Ubeda, Antonio | solicitud de patente |
